NorthWest Biotherapeutics Inc (NWBO)

[muee88]

Two things to consider:

(1) we’re about to receive a patent on the treatment of glioblastoma using a combination of a check point inhibitors such as Keytruda and a dendritic cell vaccine in which dendritic cells are pulsed with a glioma antigen;

(2) the trial description website explains that another name for the ALT-DC vaccine is a dendritic cell-pulsed tumor cell lysate vaccine.

Would be quite odd if the trial was using something other than DCVAX as NWBO would have protection over that combo. I can’t see other companies funding a trial for which they won’t ultimately control the product.